Telix Pharmaceuticals Lim... (TLX)
NASDAQ: TLX
· Real-Time Price · USD
10.19
-0.09 (-0.88%)
At close: Oct 06, 2025, 11:44 AM
Telix Pharmaceuticals Income Statement
Financials in AUD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 | Q4 2022 | Q2 2022 | Q4 2021 | Q2 2021 |
| Period Ending | Jun 30, 2025 | Dec 31, 2024 | Jun 30, 2024 | Dec 31, 2023 | Jun 30, 2023 | Dec 31, 2022 | Jun 30, 2022 | Dec 31, 2021 | Jun 30, 2021 |
Revenue | 593.11M | 594.24M | 188.96M | 281.71M | 220.83M | 136.05M | 24.05M | 4.69M | 2.91M |
Cost of Revenue | 304.77M | 208.45M | 65.08M | 57.74M | 130.02M | 91.16M | 39.62M | 23.54M | 14.09M |
Gross Profit | 288.34M | 385.8M | 123.88M | 223.97M | 90.81M | 44.89M | -15.57M | -18.86M | -11.18M |
Operating Income | 15.79M | 68.38M | 13.75M | 20.07M | 31.44M | -9.7M | -63.49M | -49.92M | -31.6M |
Interest Income | n/a | 10.25M | 610K | 566K | 453K | 214K | 1K | 89K | 74K |
Pretax Income | -7.35M | 46.91M | 9.14M | 15.39M | -12.3M | -27.92M | -70.7M | -61.99M | -37.05M |
Net Income | -3.48M | 38.24M | 11.68M | 19.53M | -14.32M | -33.19M | -70.89M | -48M | -32.51M |
Selling & General & Admin | 146.92M | 111.82M | 64.25M | 105.5M | 28.93M | 21.58M | 23.08M | 10.59M | 6.75M |
Research & Development | 123.96M | 75.25M | 45.78M | 98.4M | 30.45M | 33.01M | 24.84M | 20.46M | 13.67M |
Other Expenses | 1.68M | 130.35M | 96K | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 272.56M | 317.42M | 110.13M | 203.9M | 59.37M | 54.59M | 47.92M | 31.06M | 20.42M |
Interest Expense | n/a | 16.52M | 4.94M | 548K | 442K | 268K | 138K | 104K | 85K |
Selling & Marketing Expenses | 74.41M | 48.16M | n/a | 25.94M | 5.6M | 27.61M | 10.36M | 3.5M | 2.39M |
Cost & Expenses | 577.32M | 525.87M | 175.21M | 261.64M | 189.4M | 145.75M | 87.54M | 54.6M | 34.51M |
Income Tax Expense | 3.87M | 8.67M | -2.54M | -4.14M | 2.02M | 5.27M | 188K | -14M | -4.53M |
Shares Outstanding (Basic) | 337.21M | 331.23M | 334.23M | 323.73M | 317.62M | 316.34M | 307.33M | 283.02M | 281.02M |
Shares Outstanding (Diluted) | 337.2M | 345.19M | 350.75M | 323.73M | 317.62M | 316.34M | 307.33M | 283.02M | 281.02M |
EPS (Basic) | -0.01 | 0.12 | 0.03 | 0.06 | -0.05 | -0.1 | -0.23 | -0.17 | -0.12 |
EPS (Diluted) | -0.01 | 0.11 | 0.03 | 0.06 | -0.05 | -0.1 | -0.23 | -0.17 | -0.12 |
EBITDA | 8.91M | 76.8M | 40.29M | 22.99M | 34.72M | -7.05M | -60.76M | -47.29M | -28.79M |
EBIT | -1.76M | 78.46M | 14.09M | 20.9M | -11.86M | -27.65M | -70.56M | -61.89M | -36.69M |
Depreciation & Amortization | 10.67M | -2M | 3.66M | 2.09M | 3.29M | 2.66M | 2.74M | 2.63M | 2.81M |